Google Employee Charged in 1M Polymarket Insider Trading Bet Over Search Term
Expro Group Holdings Upgraded to Hold by Freedom Broker Following Strong Q1 Results
New Tax Season Rules for Online Sellers and EV Owners May Offer Savings
Consumer Sentiment Remains Depressed Economic Headwinds from Inflation Geopolitical Conflicts and Tariffs Weigh on Americans
ReadytoDrink Cocktail Market Maintains Growth Momentum in 2026
Cement Makers Project 78 Growth in FY27 Amid West Asia Headwinds But Industry Growth Could Be Moderate at 555
ICICI Bank IBN Q1 2026 Earnings Modest EPS Beat Supports Slight Stock Upswing
STVN Q1 2026 Earnings EPS Beats Estimates by 5 Stock Rises
Block Inc XYZ Q1 2026 Earnings Strong EPS Beat of 2443 Surprises Markets Shares Dip Slightly
KVUE Q1 2026 Earnings Strong EPS Beat Despite Tepid Market Response
DT Midstream Q1 2026 Earnings Earnings Beat Estimates by Nearly 10
LKQ Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Stock Edges Higher
RenaissanceRe RNR Holds Near Support After Modest Decline Reinsurance Sector in Focus
Palantir Technologies PLTR Dips 2 Support and Resistance Levels in Focus
Brookfield Infrastructure Subordinated Notes BIPJ Edge Higher as Income Seekers Return Resistance in Focus
PIMCO Dynamic Income Fund PDI Holds Steady Near 1666 as IncomeOriented Investors Eye Yield
Marsh MRSH Slips Slightly Amid RangeBound Trading Key Levels in Focus
Select Medical Holdings SEM Holds Steady Near Support Testing Key Resistance Zone
Corcept Therapeutics CORT Surges 26 Momentum Testing Key Resistance Zone
Atlanticus Holdings Senior Notes ATLCL Hold Steady at 2515 Amidst Stable Yield Considerations
Credit Suisse Asset Management Income Fund CIK Edges Lower as Resistance Holds
Praetorian Acquisition Corp Units PTORU Holding Steady at 100 Analysis of Key Levels and Potential Catalysts
Electronic Arts EA Holds Near 200 as Slight Pullback Tests ShortTerm Support
Jobless Claims Decline to Lowest Level Since MidMay Signaling Labor Market Resilience
CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates Amid Clinical Progress
Liminatus Pharma LIMN Shares Slide 325 as Selling Pressure Mounts Near Support